Absorption, Distribution, Metabolism, and Excretion of [14C]-Volixibat in Healthy Men: Phase 1 Open-Label Study
Crossref DOI link: https://doi.org/10.1007/s13318-017-0429-7
Published Online: 2017-07-12
Published Print: 2018-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Siebers, Nicholas http://orcid.org/0000-0001-5126-7774
Palmer, Melissa
Silberg, Debra G.
Jennings, Lee
Bliss, Caleb
Martin, Patrick T.
Funding for this research was provided by:
Shire Human Genetic Therapies Inc. (Lexington, MA, USA)
License valid from 2017-07-12